Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

, Inc.
Condensed Statements of Operations(in thousands, except per share data)Quarters Ended
December 31,Years EndedDecember 31,2012201120122011(unaudited)(unaudited)Revenues

$1,521$3,389$9,353$17,744Operating expenses:Research and development

3,0643,87814,34817,416General and administrative

1,6272,0239,1027,810Total operating expenses

4,6915,90123,45025,226Operating loss

(3,170)(2,512)(14,097)(7,482)Other income:Interest and other income, net

1184241Net loss

$(3,159)$(2,504)$(14,055)$(7,441)Basic and diluted net loss per share

$(0.24)$(0.19)$(1.09)$(0.58)Shares used in computation of basicand diluted net loss per share

12,94612,93412,94012,921GenVec, Inc.Selected Balance Sheet Information(in thousands)As of December 31,20122011(unaudited)Cash, cash equivalents and short-term investments$15,255$26,446Working capital12,74125,739Total assets17,43030,150Stockholders' equity13,74326,538 Retail Investor and Media Contact: Institutional Investor Contact:GenVec, Inc.

S.A. Noonan CommunicationsDouglas J. Swirsky

Susan A. Noonan(240) 632-5510

(212) 966-3650dswirsky@genvec.com 

susan@sanoonan.com


'/>"/>
SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014  Decision Resources Group ... (P&R) decision criteria and payer requirements in ... into each country, allow pharma to leverage ... Global market access is extremely complex, with ... requirements and challenges—and a vast variety of ...
(Date:9/23/2014)... 23, 2014 Research and Markets  has announced ... report to their offering. Diabetes is ... globe. Over 382 million people are estimated to be currently ... to 592 million by 2035. With a very high ... and India , an increasing ...
(Date:9/23/2014)... DUBLIN , September 23, 2014 /PRNewswire/ ... ) has announced the addition of the  ...  report to their offering.  ... injectable drug delivery market holds significant potential ... with vials and painful needles to the ...
Breaking Medicine Technology:Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5
... February 23 BN,ImmunoTherapeutics, Inc. today provided updated ... vaccine, MVA-BN(R)-HER2, in development as,therapy of metastatic breast ... its primary endpoint with regards to safety and ... immune response was,detected in approximately 70% of evaluated ...
... An international team of,researchers has evaluated ... the knee, and the results have been ... journal "Osteoarthritis and Cartilage".,The researchers followed 376 ... treatments. After six months as well as ...
Cached Medicine Technology:BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine 2BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine 3New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years 2
(Date:9/23/2014)... Randy Dotinga HealthDay Reporter ... cholesterol-lowering drugs while in the hospital for a hemorrhagic stroke ... than four times more likely to survive than people who ... People taking the commonly used drugs known as statins were ... to a rehabilitation facility, the study reports. When it ...
(Date:9/23/2014)... Investigators at Cincinnati Children,s Hospital Medical Center have ... gastritis (EG). The study, published in The ... that EG is a systemic disorder that has ... gastrointestinal tract, involves a series of allergy-associated-immune mechanisms ... is distinct from that of a related disorder, ...
(Date:9/23/2014)... Klose, professor of biology and a researcher in UTSA,s ... up with researchers at Ruhr University in Bochum, Germany ... findings were released this week in an article published ... Sciences . , Cholera is an acute infection caused ... with the bacterium Vibrio cholerae . An estimated ...
(Date:9/23/2014)... The community college system represents a potential source ... who will serve poor communities; however, there are ... colleges to four-year universities to medical schools. The ... recruitment, outreach and admissions practices be more inclusive ... Researchers from UCLA, UC San Francisco and San ...
(Date:9/23/2014)... "Obamacare" was signed into law in 2010 ... system since the 1960s. Designed to provide medical care ... an unwarranted intrusion into the affairs of private businesses ... healthcare systems in six Western countries, published last month ... move away from privatized medicine toward state-sponsored healthcare systems. ...
Breaking Medicine News(10 mins):Health News:Cholesterol-Lowering Drugs May Help After Certain Strokes 2Health News:Cholesterol-Lowering Drugs May Help After Certain Strokes 3Health News:Advancing the understanding of an understudied food allergy disorder 2Health News:Advancing the understanding of an understudied food allergy disorder 3Health News:UTSA microbiologists discover regulatory thermometer that controls cholera 2Health News:Medical students who attended community college likelier to serve poor communities 2Health News:Life, liberty, and the pursuit of healthcare? 2
... about glioblastoma multiforme: the malignant brain tumor is aggressive, ... In a novel effort to unravel the ... Cincinnati (UC) researchers has begun sequencing individual glioblastoma genomes ... by mapping the various DNA rearrangements of glioblastoma tumors ...
... the majority of people who binge drink. This may come ... episodes of heavy alcohol drinking within the previous two weeks ... of 10th graders, 28 percent of 12th grade seniors and ... 12 to 20 years of age, marks a critical period ...
... Disorder, or ADHD, is widely recognized by the medical community, ... as many as six percent of all children suffer from ... of refined motor skills, children with DCD tend to have ... school. They appear to be uncoordinated and many parents ...
... The Royal Marsden Hospital Manual of Clinical Nursing Procedures ... that organises 15 key chapters into four key stages ... areas such as risk management and preparing patients for ... the world-renowned UK centre of excellence, the Manual provides ...
... News) -- The brains of people with autism concentrate more ... activity in areas used to plan and control thoughts and ... why people with autism have exceptional visual abilities, said the ... from 26 brain imaging studies that were conducted over 15 ...
... can be assessed by examining the epithelial cells found ... at the AACR 102nd Annual Meeting 2011, held April ... to provide a personalized assessment of breast cancer risk, ... of veterinary and animal sciences at the University of ...
Cached Medicine News:Health News:University of Cincinnati team to track tumor DNA through bloodstream 2Health News:University of Cincinnati team to track tumor DNA through bloodstream 3Health News:Underage binge drinking can create lasting brain changes 2Health News:Clumsy kids who don't 'grow out of it' 2Health News:Patient's journey format drives new edition of vital student nurse manual 2Health News:Patient's journey format drives new edition of vital student nurse manual 3Health News:Brains of People with Autism Focus More on Visual Skills 2Health News:Breast milk may provide a personalized screen of breast cancer risk 2
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
Xenon surgical headlight system is durable, comfortable, lightweight and deliver dependable bright light through a patented shielded fiber optic bundle. It is easy to wear....
Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost....
View Mex-3 is designed for out-patient surgery, hospital rounds and house calls....
Medicine Products: